Bryan Castillo-Rojas
Ph.D. Student in Microbiology and Immunology, admitted Summer 2026
Education & Certifications
-
BA, University of California, Berkeley, Molecular Cell Biology (2023)
Work Experience
-
Research Associate, San Francisco Biohub (1/17/2023 - 6/5/2026)
Location
San Francisco, California
All Publications
-
Neuroinvasive Trichodysplasia Spinulosa-Associated Polyomavirus Infection.
The New England journal of medicine
2026; 395 (10): 1032-1034
View details for DOI 10.1056/NEJMc2602730
View details for PubMedID 42715570
-
Flavivirus NS1-triggered endothelial dysfunction promotes virus dissemination.
PLoS pathogens
2025; 21 (12): e1013811
Abstract
The Flaviviridae are a family of viruses that include the important arthropod-borne human pathogens dengue virus, West Nile virus, Zika virus, Japanese encephalitis virus, and yellow fever virus. Flavivirus nonstructural protein 1 (NS1) is essential for virus replication but is also secreted from virus-infected cells. Extracellular NS1 acts as a virulence factor during flavivirus infection in multiple ways, including triggering endothelial dysfunction and vascular leak via interaction with endothelial cells. While the role of NS1 in inducing vascular leak and exacerbating pathogenesis is well appreciated, if and how NS1-triggered endothelial dysfunction promotes virus infection remains obscure. Flaviviruses have a common need to disseminate from circulation into specific tissues where virus-permissive cells reside. Tissue-specific dissemination is associated with disease manifestations of a given flavivirus, but mechanisms dictating virus dissemination are unclear. Here we show that NS1-mediated endothelial dysfunction promotes virus dissemination in vitro and in vivo. In mouse models of dengue virus infection, we show that anti-NS1 antibodies decrease virus dissemination, while the addition of exogenous NS1 promotes virus dissemination. Using an in vitro system, we show that NS1 promotes virus dissemination in two distinct ways: (1) promoting crossing of barriers and (2) increasing infectivity of target cells in a tissue- and virus-specific manner. The capacity of NS1 to modulate infectivity correlates with a physical association between virions and NS1, suggesting a potential NS1-virion interaction. Taken together, our study indicates that flavivirus NS1 acts as a viral toxin and promotes virus dissemination across endothelial barriers, providing an evolutionary basis for virus-triggered vascular leak.
View details for DOI 10.1371/journal.ppat.1013811
View details for PubMedID 41474801
View details for PubMedCentralID PMC12779140
-
The inflammasome pathway is activated by dengue virus non-structural protein 1 and is protective during dengue virus infection
PLOS PATHOGENS
2024; 20 (4): e1012167
Abstract
Dengue virus (DENV) is a medically important flavivirus causing an estimated 50-100 million dengue cases annually, some of whom progress to severe disease. DENV non-structural protein 1 (NS1) is secreted from infected cells and has been implicated as a major driver of dengue pathogenesis by inducing endothelial barrier dysfunction. However, less is known about how DENV NS1 interacts with immune cells and what role these interactions play. Here we report that DENV NS1 can trigger activation of inflammasomes, a family of cytosolic innate immune sensors that respond to infectious and noxious stimuli, in mouse and human macrophages. DENV NS1 induces the release of IL-1β in a caspase-1 dependent manner. Additionally, we find that DENV NS1-induced inflammasome activation is independent of the NLRP3, Pyrin, and AIM2 inflammasome pathways, but requires CD14. Intriguingly, DENV NS1-induced inflammasome activation does not induce pyroptosis and rapid cell death; instead, macrophages maintain cellular viability while releasing IL-1β. Lastly, we show that caspase-1/11-deficient, but not NLRP3-deficient, mice are more susceptible to lethal DENV infection. Together, these results indicate that the inflammasome pathway acts as a sensor of DENV NS1 and plays a protective role during infection.
View details for DOI 10.1371/journal.ppat.1012167
View details for Web of Science ID 001209049700004
View details for PubMedID 38662771
View details for PubMedCentralID PMC11075848
-
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
NATURE COMMUNICATIONS
2022; 13 (1): 7630
Abstract
Severe COVID-19 is associated with epithelial and endothelial barrier dysfunction within the lung as well as in distal organs. While it is appreciated that an exaggerated inflammatory response is associated with barrier dysfunction, the triggers of vascular leak are unclear. Here, we report that cell-intrinsic interactions between the Spike (S) glycoprotein of SARS-CoV-2 and epithelial/endothelial cells are sufficient to induce barrier dysfunction in vitro and vascular leak in vivo, independently of viral replication and the ACE2 receptor. We identify an S-triggered transcriptional response associated with extracellular matrix reorganization and TGF-β signaling. Using genetic knockouts and specific inhibitors, we demonstrate that glycosaminoglycans, integrins, and the TGF-β signaling axis are required for S-mediated barrier dysfunction. Notably, we show that SARS-CoV-2 infection caused leak in vivo, which was reduced by inhibiting integrins. Our findings offer mechanistic insight into SARS-CoV-2-triggered vascular leak, providing a starting point for development of therapies targeting COVID-19.
View details for DOI 10.1038/s41467-022-34910-5
View details for Web of Science ID 000969991400003
View details for PubMedID 36494335
View details for PubMedCentralID PMC9734751
https://orcid.org/0000-0001-8120-5478